Pemphigus family of diseases

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Pemphigus is a group of autoimmune blistering diseases of the skin and mucous membranes, which are mediated by immunoglobulin G (IgG) autoantibodies against the cadherin type of cell-cell adhesion molecules in desmosomes, desmogleins. Pemphigus is histologically characterized by acantholysis, that is, intraepidermal blisters due to the loss of cell-cell adhesion of keratinocytes, and immunopathologically by the finding of in-vivo-bound and circulating IgG autoantibodies directed against the cell surface of keratinocytes. Pemphigus has three major forms: pemphigus vulgaris, pemphigus foliaceus, and paraneoplastic pemphigus. Pemphigus vegetans is a variant of pemphigus vulgaris. Pemphigus erythematosus is a localized variant of pemphigus foliaceus, and fogo selvagem is an endemic variant of pemphigus foliaceus. Patients with pemphigus vulgaris and pemphigus foliaceus have IgG autoantibodies against desmoglein 3 and desmoglein 1, respectively, while patients with paraneoplastic pemphigus have IgG autoantibodies against plakin molecules in addition to desmogleins. Systemic corticosteroids are the mainstay of therapy for pemphigus, and adjuvant therapies, including immunosuppressive agents, plasmapheresis, and high-dose intravenous immunoglobulin, are used for severe cases.

Original languageEnglish
Title of host publicationClinical and Basic Immunodermatology
PublisherSpringer London
Pages739-749
Number of pages11
ISBN (Print)9781848001640
DOIs
Publication statusPublished - 2008

Fingerprint

Pemphigus
Autoantibodies
Desmogleins
Immunoglobulin G
Keratinocytes
Desmoglein 3
Desmoglein 1
Acantholysis
Desmosomes
Plasmapheresis
Intravenous Immunoglobulins
Cell Adhesion Molecules
Cadherins
Blister
Immunosuppressive Agents
Cell Adhesion
Autoimmune Diseases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Amagai, M. (2008). Pemphigus family of diseases. In Clinical and Basic Immunodermatology (pp. 739-749). Springer London. https://doi.org/10.1007/978-1-84800-165-7_42

Pemphigus family of diseases. / Amagai, Masayuki.

Clinical and Basic Immunodermatology. Springer London, 2008. p. 739-749.

Research output: Chapter in Book/Report/Conference proceedingChapter

Amagai, M 2008, Pemphigus family of diseases. in Clinical and Basic Immunodermatology. Springer London, pp. 739-749. https://doi.org/10.1007/978-1-84800-165-7_42
Amagai M. Pemphigus family of diseases. In Clinical and Basic Immunodermatology. Springer London. 2008. p. 739-749 https://doi.org/10.1007/978-1-84800-165-7_42
Amagai, Masayuki. / Pemphigus family of diseases. Clinical and Basic Immunodermatology. Springer London, 2008. pp. 739-749
@inbook{81c17a97b6f840c8ac8f9aa6323416d3,
title = "Pemphigus family of diseases",
abstract = "Pemphigus is a group of autoimmune blistering diseases of the skin and mucous membranes, which are mediated by immunoglobulin G (IgG) autoantibodies against the cadherin type of cell-cell adhesion molecules in desmosomes, desmogleins. Pemphigus is histologically characterized by acantholysis, that is, intraepidermal blisters due to the loss of cell-cell adhesion of keratinocytes, and immunopathologically by the finding of in-vivo-bound and circulating IgG autoantibodies directed against the cell surface of keratinocytes. Pemphigus has three major forms: pemphigus vulgaris, pemphigus foliaceus, and paraneoplastic pemphigus. Pemphigus vegetans is a variant of pemphigus vulgaris. Pemphigus erythematosus is a localized variant of pemphigus foliaceus, and fogo selvagem is an endemic variant of pemphigus foliaceus. Patients with pemphigus vulgaris and pemphigus foliaceus have IgG autoantibodies against desmoglein 3 and desmoglein 1, respectively, while patients with paraneoplastic pemphigus have IgG autoantibodies against plakin molecules in addition to desmogleins. Systemic corticosteroids are the mainstay of therapy for pemphigus, and adjuvant therapies, including immunosuppressive agents, plasmapheresis, and high-dose intravenous immunoglobulin, are used for severe cases.",
author = "Masayuki Amagai",
year = "2008",
doi = "10.1007/978-1-84800-165-7_42",
language = "English",
isbn = "9781848001640",
pages = "739--749",
booktitle = "Clinical and Basic Immunodermatology",
publisher = "Springer London",

}

TY - CHAP

T1 - Pemphigus family of diseases

AU - Amagai, Masayuki

PY - 2008

Y1 - 2008

N2 - Pemphigus is a group of autoimmune blistering diseases of the skin and mucous membranes, which are mediated by immunoglobulin G (IgG) autoantibodies against the cadherin type of cell-cell adhesion molecules in desmosomes, desmogleins. Pemphigus is histologically characterized by acantholysis, that is, intraepidermal blisters due to the loss of cell-cell adhesion of keratinocytes, and immunopathologically by the finding of in-vivo-bound and circulating IgG autoantibodies directed against the cell surface of keratinocytes. Pemphigus has three major forms: pemphigus vulgaris, pemphigus foliaceus, and paraneoplastic pemphigus. Pemphigus vegetans is a variant of pemphigus vulgaris. Pemphigus erythematosus is a localized variant of pemphigus foliaceus, and fogo selvagem is an endemic variant of pemphigus foliaceus. Patients with pemphigus vulgaris and pemphigus foliaceus have IgG autoantibodies against desmoglein 3 and desmoglein 1, respectively, while patients with paraneoplastic pemphigus have IgG autoantibodies against plakin molecules in addition to desmogleins. Systemic corticosteroids are the mainstay of therapy for pemphigus, and adjuvant therapies, including immunosuppressive agents, plasmapheresis, and high-dose intravenous immunoglobulin, are used for severe cases.

AB - Pemphigus is a group of autoimmune blistering diseases of the skin and mucous membranes, which are mediated by immunoglobulin G (IgG) autoantibodies against the cadherin type of cell-cell adhesion molecules in desmosomes, desmogleins. Pemphigus is histologically characterized by acantholysis, that is, intraepidermal blisters due to the loss of cell-cell adhesion of keratinocytes, and immunopathologically by the finding of in-vivo-bound and circulating IgG autoantibodies directed against the cell surface of keratinocytes. Pemphigus has three major forms: pemphigus vulgaris, pemphigus foliaceus, and paraneoplastic pemphigus. Pemphigus vegetans is a variant of pemphigus vulgaris. Pemphigus erythematosus is a localized variant of pemphigus foliaceus, and fogo selvagem is an endemic variant of pemphigus foliaceus. Patients with pemphigus vulgaris and pemphigus foliaceus have IgG autoantibodies against desmoglein 3 and desmoglein 1, respectively, while patients with paraneoplastic pemphigus have IgG autoantibodies against plakin molecules in addition to desmogleins. Systemic corticosteroids are the mainstay of therapy for pemphigus, and adjuvant therapies, including immunosuppressive agents, plasmapheresis, and high-dose intravenous immunoglobulin, are used for severe cases.

UR - http://www.scopus.com/inward/record.url?scp=79958857117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958857117&partnerID=8YFLogxK

U2 - 10.1007/978-1-84800-165-7_42

DO - 10.1007/978-1-84800-165-7_42

M3 - Chapter

SN - 9781848001640

SP - 739

EP - 749

BT - Clinical and Basic Immunodermatology

PB - Springer London

ER -